Weaver syndrome is a rare genetic overgrowth condition in which children are unusually large before and after birth, have bones that mature faster than expected, and develop a set of distinctive facial features. It is caused by mutations in a gene called EZH2, which helps regulate how other genes are switched on and off during development. The condition was first described in 1974, but the genetic cause was only pinpointed in 2011, and much about how the syndrome unfolds over a lifetime is still being worked out.
Recognizing the Physical Features
The hallmark of Weaver syndrome is overgrowth that starts in the womb. Babies tend to be heavier and longer than average at birth, and rapid growth continues through childhood. Height typically tracks well above the normal range, and the head is disproportionately large, a feature called macrocephaly. Alongside the overgrowth, skeletal maturation runs ahead of schedule: bone‑age X‑rays consistently show bones that look older than the child’s actual age.1The Journal of Clinical Endocrinology & Metabolism. Ezh2 Mutations Found in the Weaver Overgrowth Syndrome Cause a Partial Loss of H3K27 Histone Methyltransferase Activity One particular pattern stands out: the wrist (carpal) bones tend to be far more advanced than the finger bones, a quirk that can help separate Weaver syndrome from other overgrowth conditions.2American Journal of Human Genetics. Mutations in EZH2 Cause Weaver Syndrome
The face has its own signature, though it can be subtle. A broad forehead, almond‑shaped eye openings, large low‑set ears, and a pointed chin with a deep horizontal crease are commonly described. That chin crease is sometimes called a “stuck‑on chin” in clinical literature, and it is one of the features most suggestive of Weaver syndrome specifically.2American Journal of Human Genetics. Mutations in EZH2 Cause Weaver Syndrome Other findings include camptodactyly, a permanent bending of one or more finger joints, and increased muscle tone. Some children also have a distinctively hoarse, low‑pitched voice.3PubMed. The Weaver syndrome: a rare type of primordial overgrowth
Developmental and Cognitive Effects
Intellectual disability in Weaver syndrome ranges widely, from very mild to moderate. Many children show delayed motor milestones, slower speech development, and some degree of cognitive delay.1The Journal of Clinical Endocrinology & Metabolism. Ezh2 Mutations Found in the Weaver Overgrowth Syndrome Cause a Partial Loss of H3K27 Histone Methyltransferase Activity The word “variable” comes up constantly in clinical reports, and for good reason: some individuals function near the typical range with early intervention, while others need ongoing support. Because the degree of cognitive involvement is unpredictable from the genetic mutation alone, developmental assessments in infancy and early childhood are a standard part of managing the condition.
The increased muscle tone seen in many children can compound motor delays. Babies may feel unusually stiff rather than floppy, which is the opposite of what many other genetic syndromes produce. That stiffness, combined with large body size, can make early physical milestones like rolling, sitting, and walking more of a challenge.
What Causes Weaver Syndrome
In 2011, researchers used whole‑exome sequencing on two families with Weaver syndrome, including one of the families originally described in 1974, and found that both carried new (de novo) mutations in a gene called EZH2. A third classically affected individual confirmed the link.4PubMed Central. Mutations in EZH2 cause Weaver syndrome Additional sequencing studies soon identified more than a dozen further EZH2 mutations in people with overgrowth features.5PubMed Central. Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height
EZH2 encodes a protein that is the working part of a molecular complex called PRC2. This complex is responsible for chemically tagging a specific spot on histone proteins, the spools around which DNA is wound. When that tag is placed, the nearby stretch of DNA gets silenced, meaning the genes there stay turned off. It is a fundamental mechanism for controlling which genes are active in which cell types during growth and development.2American Journal of Human Genetics. Mutations in EZH2 Cause Weaver Syndrome
The mutations that cause Weaver syndrome do not completely destroy EZH2’s activity. Instead, laboratory studies show they cause a partial loss of function: the mutant protein still works, but not as efficiently as the normal version.6The Journal of Clinical Endocrinology & Metabolism. Ezh2 Mutations Found in the Weaver Overgrowth Syndrome Cause a Partial Loss of H3K27 Histone Methyltransferase Activity 7PubMed Central. Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro The result is that certain genes that should be silenced during development are instead left partially active, which appears to drive the excess growth and other features of the syndrome.
Inheritance and Why More Males Are Diagnosed
Weaver syndrome follows an autosomal dominant pattern, meaning a single mutated copy of EZH2 is enough to cause the condition. If a person with Weaver syndrome has children, each child has a 50 percent chance of inheriting the variant.8PubMed Central. Clinical and genetic characterization of Weaver syndrome: A case report of an EZH2 mutation and review of the literature In practice, though, the vast majority of cases arise de novo, meaning the mutation appears for the first time in the affected child and was not present in either parent.
A curious pattern in the published cases is that roughly three times as many males as females have been diagnosed. This does not necessarily mean the mutation strikes boys more often. One hypothesis is that females tend to present with milder features, making them harder to identify clinically and leading to underdiagnosis. If true, there could be a meaningful number of girls and women carrying EZH2 mutations who have never received a formal diagnosis because their overgrowth and facial features fall closer to the normal range.
A minority of Weaver syndrome cases are caused not by EZH2 mutations but by mutations in two other genes, EED and SUZ12, which encode the other core components of the same PRC2 complex.8PubMed Central. Clinical and genetic characterization of Weaver syndrome: A case report of an EZH2 mutation and review of the literature Because all three proteins work together to silence genes, it makes sense biologically that disrupting any one of them could produce overlapping symptoms.
Why Diagnosis Is Difficult
Getting a Weaver syndrome diagnosis based on clinical observation alone is genuinely hard. The facial features that distinguish it from other overgrowth syndromes can be subtle, and they tend to become less obvious with age. A study of individuals with confirmed EZH2 mutations noted that the facial gestalt was often not immediately recognizable, especially in older patients.9PubMed. Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype Clinicians who see very few cases over a career may not pick up on the combination of a broad forehead, almond‑shaped eyes, and a creased chin, particularly when overgrowth is the feature that prompted the referral in the first place.
Genetic testing has largely resolved this problem. Sequencing EZH2 provides an objective confirmation when the clinical picture is ambiguous, and it can definitively separate Weaver syndrome from conditions that look similar on the surface. A newer approach uses genome‑wide DNA methylation analysis. Because EZH2 mutations alter how genes are silenced, they leave a characteristic chemical “signature” across the genome. Researchers demonstrated that this signature is highly specific and sensitive for Weaver syndrome, and it can even be used to classify EZH2 variants of uncertain significance, variants where it is not clear from the DNA sequence alone whether the mutation is harmful.10PubMed Central. DNA Methylation Signature for EZH2 Functionally Classifies Sequence Variants in Three PRC2 Complex Genes This is particularly useful because many rare conditions are plagued by ambiguous genetic test results that leave families in limbo.
Telling Weaver Syndrome Apart from Sotos Syndrome
The condition most commonly confused with Weaver syndrome is Sotos syndrome. Both feature overgrowth, macrocephaly, advanced bone age, and developmental delay, and for decades geneticists debated whether they were really two faces of the same disorder. The confusion deepened when researchers found that some individuals clinically diagnosed with Weaver syndrome actually carried mutations in NSD1, the gene responsible for Sotos syndrome.11PubMed Central. Spectrum of NSD1 mutations in Sotos and Weaver syndromes That discovery fuelled a genuine debate about whether the two syndromes were distinct entities or just variations along one spectrum.
The identification of EZH2 as the primary Weaver gene largely settled the argument. Weaver syndrome and Sotos syndrome are caused by mutations in different genes, though they share clinical territory.2American Journal of Human Genetics. Mutations in EZH2 Cause Weaver Syndrome The features that tilt toward Weaver include the characteristic chin crease, overgrowth that begins before birth rather than mainly after, and the distinctive wrist‑bone advancement pattern on X‑ray. Sotos syndrome, by contrast, tends to produce a more recognizable long, narrow face and a more pronounced forehead. But the overlap remains real enough that genetic testing, rather than clinical impression alone, is the reliable way to distinguish them.
The fact that some NSD1‑positive patients were originally labeled as Weaver cases is an important historical footnote. It means older published case series of “Weaver syndrome” include a mixed genetic population, which can muddy attempts to define the precise symptom profile. More recent studies that start with genetically confirmed EZH2 cases have sharpened the clinical picture considerably.
Other Overgrowth Syndromes in the Differential
The family of overgrowth and intellectual disability syndromes extends well beyond Sotos and Weaver. Tatton‑Brown‑Rahman syndrome, caused by mutations in a different gene called DNMT3A, shares features like tall stature and cognitive differences but tends to involve increased body weight more prominently and has its own distinct facial appearance.12PubMed Central. The Tatton-Brown-Rahman Syndrome: A clinical study of 55 individuals with de novo constitutive DNMT3A variants Malan syndrome and overgrowth linked to CHD8 variants round out the list of conditions that a genetics team would consider when evaluating a child with unexplained overgrowth and developmental delay.
What links many of these conditions at the molecular level is that the genes involved all play roles in how DNA is packaged and read. EZH2 modifies histones, DNMT3A modifies DNA itself, and NSD1 modifies a different histone mark. They are all part of the cell’s system for deciding which genes should be active and which should stay silent. When any part of this system is weakened, the result tends to be excessive growth and developmental disruption, though the specific clinical features differ enough to form separate syndromes.
Management and What Families Can Expect
There is no treatment that corrects the underlying genetic problem in Weaver syndrome. Management is supportive and tailored to the individual child’s needs. Early developmental therapies, including speech therapy, occupational therapy, and physiotherapy, are generally recommended to address motor and cognitive delays. Because the degree of intellectual disability varies so much, the level of educational support needed ranges from minimal accommodations to specialized settings.
Orthopedic monitoring may be warranted, given the advanced skeletal maturation and the finger joint contractures some individuals develop. The overgrowth itself does not typically require medical intervention, though tall stature and large head circumference should be tracked to ensure they follow a predictable growth curve and are not signs of a separate complication. Standard pediatric screenings apply, and any unusual findings can be evaluated in the context of the syndrome.
Because EZH2 is also known to play a role in certain cancers when it gains abnormal extra function through somatic mutations acquired during life, families sometimes worry about cancer risk. The mutations that cause Weaver syndrome are a partial loss of function, which is the opposite direction from the gain‑of‑function changes seen in many EZH2‑related cancers.7PubMed Central. Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro There have been scattered reports of tumors in individuals with Weaver syndrome, but the condition is so rare that establishing a clear, quantified cancer risk has not been possible. Most genetics teams recommend standard cancer‑screening guidelines rather than aggressive surveillance, while acknowledging that long‑term data remain thin.
The EZH2 Connection to Normal Height Variation
An unexpected finding from the research into Weaver syndrome is that common, much less dramatic variants near or within EZH2 are associated with normal variation in human height in the general population.5PubMed Central. Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height The severe, rare mutations that cause Weaver syndrome sit at one extreme of a continuum: they dramatically impair gene silencing and produce a recognizable syndrome. Milder genetic variation in the same region nudges height up or down without causing disease. This kind of spectrum, where rare severe variants cause a syndrome and common mild variants influence a normal trait, has been observed for other genes involved in growth and metabolism. For Weaver syndrome families, it serves as a reminder that EZH2 is not a gene the body can do without; it is central to growth regulation, and even small changes in its activity have measurable effects.
For researchers, the link between rare overgrowth syndromes and everyday height differences has been productive. Studying what goes wrong in Weaver syndrome has illuminated how the PRC2 complex regulates skeletal growth more broadly, opening avenues of investigation that extend far beyond a single rare condition. It is one of those cases where understanding a rare disease pays dividends for understanding normal biology.